Decitabine in Treating Patients With Myelofibrosis

Clinical trial NCT00095784 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT00095784
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Myelofibrosis Secondary Myelofibrosis

Start date: 2004-09-29
Primary completion: 2008-07-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.